Gilead Sciences, Inc.

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Overview
Date Founded

1987

Headquarters

333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404

Type of Company

Public

Employees (Worldwide)

11.8K

Industries

Biotechnology
Hospitals & Patient Services
Industrial Machinery & Manufacturing

Company Description

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Contact Data
Trying to get in touch with decision makers at Gilead Sciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Chief Financial Officer

Chief Financial Officer

Executive Vice President, Corporate Affairs & General Counsel

Chief Commercial Officer

Chief Medical Officer

Senior Vice President, Corporate Controller & Chief Accounting Officer

Chief Executive Officer, Kite

Executive Vice President, Pharmaceutical Development & Manufacturing

Executive Vice President, Research

Paths to Gilead Sciences, Inc.
Potential Connections via
Relationship Science
You
Gilead Sciences, Inc.
Owners & Shareholders
Details Hidden

CWGI is the investment adviser to the American Funds Group, a family of 30 funds marketed to individuals exclusively through financial advisers and other intermediaries. American Funds are also used as investment vehicles for 401ks, other retirement plans, variable annuities and 529 college savings plans. The funds have the following characteristics: (1) a long-term, value-oriented approach; (2) long-established, global research; (3) a multiple portfolio counselor system that combines teamwork with individual accountability; (4) experienced, long-tenured investment professionals; and (5) a commitment to low operating expenses, among the lowest in the fund industry. CWGI uses a Multiple Portfolio Counselor System wherein the assets of each fund are divided into smaller, more manageable portions. Research analysts typically manage a segment as well, bringing their expertise directly to bear on the fund's results and portfolio counselors are free to make their own decisions. Investment decisions are based on internal research.

Details Hidden

CWI employs a long-term, value-oriented global investment approach and a multiple portfolio manager system that combines teamwork and individual accountability. The firm utilizes fundamental research to gather in-depth information on markets and companies around the world. They also employ a security-by-security approach to portfolio construction and emphasize long-term investments. Their strategies focus on determining the difference between the fundamental value of a company and its price in the marketplace. CWI offers a wide variety of equity, fixed-income and balanced investment strategies. Their strategies are categorized as global, multi-regional and regional investment strategies.

Details Hidden

CRMC's International Investors division invests primarily in the stocks of large-cap growth-oriented companies across practically all sectors. Although they invest internationally, most of their investments are in the stocks of North American companies. They maintain an investment philosophy that is distinguished by four key beliefs: (1) solid research is fundamental to sound investment decisions; (2) investment decisions should not be made lightly; (3) a long-term approach; (4) the capital system.

Recent Transactions
Details Hidden

Gilead Sciences, Inc. purchases Pionyr Immunotherapeutics, Inc.

Details Hidden

Gilead Sciences, Inc. purchases Mologen AG /Lefitolimod & Enandim Assets from Mologen AG

Details Hidden

Gilead Sciences, Inc. purchases Forty Seven, Inc.

Transaction Advisors
Legal Advisor

Advised onGilead Sciences, Inc. purchases Myogen, Inc.

Accountant

Advised onGilead Sciences, Inc. purchases NeXstar Pharmaceuticals, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Kite Pharma, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Myogen, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Kite Pharma, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases CV Therapeutics, Inc.

Advisors & Consultants
Legal Advisor

Partner In Charge-Palo Alto at Cooley LLP

Legal Advisor

Partner, Palo Alto at Cooley LLP

Legal Advisor

Partner at Cooley LLP

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

General Electric Co. is a technology and financial services company. It operates through the following segments: Power, Renewable Energy, Aviation, Healthcare, and Capital. The Power segment offers technologies, solutions, and services related to energy production, which includes gas and steam turbines, generators, and power generation services. The Renewable Energy segment provides wind turbine platforms, hardware & software, offshore wind turbines, solutions, products & services to hydropower industry, blades for onshore & offshore wind turbines, and high voltage equipment. The Aviation segment provides jet engines & turboprops for commercial airframes, maintenance, component repair, and overhaul services, as well as replacement parts, additive machines & materials, and engineering services. The Healthcare segment provides healthcare technologies in medical imaging, digital solutions, patient monitoring, and diagnostics, drug discovery, biopharmaceutical manufacturing technologies and performance enhancement solutions. The Capital segment leases & finances aircraft, aircraft engines and helicopters, and also provides financial and underwriting solutions. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Boston, MA.

Founder at Intellia Therapeutics, Inc.

Key Stats and Financials As of 2019
Market Capitalization
$75.1B
Total Enterprise Value
$83.8B
Earnings Per Share
$4.22
Revenue
$22.3B
Net Profit
$5.39B
EBITDA
$6.36B
EBITDAMargin
28.51%
Total Debt
$25.3B
Total Equity
$22.6B
Debt TEV
0.3x
Enterprise Value / Sales
3.75x
Enterprise Value EBITDAOperating
13.05x
TEVNet Income
15.55x
Three Year Compounded Annual Growth Rate Of Revenue
-9.7%
Five Year Compounded Annual Growth Rate Of Revenue
-2.15%
Non-Profit Donations & Grants
Political Donations
$3,300
2006
$2,000
2006
$2,000
2006
Investments
Details Hidden

Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT.

Details Hidden

Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, José Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA.

Details Hidden

Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.

Investors
Details Hidden

Partner at Vivo Capital LLC

Suppliers
Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Johnson & Johnson Personal Products | New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

GlobeImmune, Inc. Medical Support Services | Louisville, Colorado

GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Bristol-Myers Squibb Company Pharmaceuticals - New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Awards & Honors
Rank #86
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #86
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gilead Sciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gilead Sciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Gilead Sciences, Inc..